Bryxta 400Mg Bevacizumab Injection

Name: Bryxta 400Mg Bevacizumab Injection
Brand: Tejasvi Pharmaceuticals
Price: 6500 INR
Availability: InStock

Price 6500 INR/ Vial

Get a Price/Quote

MOQ : 10 Vials

Bryxta 400Mg Bevacizumab Injection Specification

Drug Type
Injection

Physical Form
Liquid

Dosage
400 mg/16 ml

Suitable For
Adults

Storage Instructions
Room Temperature

Bryxta 400Mg Bevacizumab Injection Trade Information

Minimum Order Quantity
10 Vials

Payment Terms
Cash in Advance (CID)

Supply Ability
100 Vials Per Month

Delivery Time
5-7 Days

Main Domestic Market
All India

About Bryxta 400Mg Bevacizumab Injection

Secure an immaculate deal on Bryxta 400Mg Bevacizumab Injectionyour last chance to reserve this valuable medication at a discount from our remarked exporter, supplier, and trader in India. This injectable drug type offers a potent 400 mg/16 ml dosage, formulated exclusively for adult use. Its liquid physical form ensures precise application, stored conveniently at room temperature. As a globally demanded product, Bryxtas remarkable efficacy delivers trusted treatment, making it ideal for healthcare professionals seeking uncompromised quality and exceptional market value.

Ideal Application and Usage of Bryxta 400Mg Bevacizumab Injection

Bryxta 400Mg Bevacizumab Injection is specifically suitable for adult patients, offering targeted therapy via intravenous administration. Its liquid formulation ensures accurate dosing and stability throughout the treatment process. This medication is essential in oncology protocols, supporting healthcare providers with its reliable results. Effective usage emerges from adherence to recommended dosage and medical guidance, ensuring the best therapeutic outcomes within hospital or clinical settings.

Sample Policy and Market Availability

Our exchange sample policy for Bryxta 400Mg Bevacizumab Injection enhances market value evaluation and domestic mar accessibility. Samples are provided under FOB Port terms, streamlining international and local trade. Supply ability remains consistent, meeting substantial market demand while supporting traders and suppliers throughout India. This responsive policy aids partners in assessing product quality and trading feasibility, reinforcing Bryxtas distinguished position within medical markets for effective patient care.

FAQs of Bryxta 400Mg Bevacizumab Injection:

Q: How should Bryxta 400Mg Bevacizumab Injection be stored for optimal efficacy?

A: Bryxta 400Mg Bevacizumab Injection should be stored at room temperature in a secure location, away from direct sunlight and moisture, to maintain its stability and potency.

Q: What is the recommended application process for Bryxta 400Mg Bevacizumab Injection?

A: The recommended process is intravenous administration by a qualified healthcare professional, ensuring correct dosage and patient safety throughout the treatment.

Q: Who is eligible for treatment with Bryxta 400Mg Bevacizumab Injection?

A: This medication is suitable for adults, specifically those undergoing targeted therapy as prescribed by medical professionals.

Q: Where is Bryxta 400Mg Bevacizumab Injection supplied and exported from?

A: Bryxta 400Mg Bevacizumab Injection is distributed and exported by trusted suppliers, traders, and exporters throughout India, with shipments available through designated FOB ports.

Q: What benefit does the sample policy provide to traders and healthcare providers?

A: The sample policy enables traders and providers to evaluate product quality and exchange terms, facilitating informed decisions and enhancing market trading opportunities.

Tell us about your requirement